Holland & Knight Health Dose: July 21, 2026

Holland & Knight Health Dose: July 21, 2026 outlines a busy congressional agenda for healthcare as the August 2026 recess approaches. It says the U.S. House has advanced all 12 FY 2027 appropriations bills and shared text for a continuing resolution through early December 2026, while Senate appropriators remain in discussions over topline funding and preparing subcommittee bills. The briefing notes that healthcare committees, including the House Committee on Energy and Commerce, will be active, with a markup of 29 bills. Those bills include measures such as the Lower Costs, More Transparency Act, plus efforts related to illicit substances and Medicare Advantage. On the House floor, it highlights the FDA Modernization Act 3.0 (H.R. 2821), the Nucleic Acid Standards for Biosecurity Act (H.R. 3029), and public health reauthorization bills. Dates listed for hearings and markups span July 20–23, 2026, including Senate HELP discussions on prescription-drug labeling and healthcare workforce programs.